To target PEA-15 in advanced breast tumours, Xie et al. developed a breast cancer specific construct (T-VISA) composed of the human telomerase reverse transcriptase (hTERT; T) promoter and a versatile transgene amplification vector VISA (VP16-GAL4-WPRE integrated systemic amplifier). The gene discussed is LGALS4; the disease is breast cancer.